Chun Ye

3 ta ish

University of California, San Francisco

1. CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

   Levi J. Rupp, Kathrin Schumann, Kole T. Roybal +4

   MaqolaOAOchiq kirish20174 iqtibos

   ABIABI:AkademIndex/2026.other.020478

2. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity

   Mikhail Binnewies, Adriana M. Mujal, Joshua L. Pollack +15

   MaqolaOAOchiq kirish20193 iqtibos

   ABIABI:AkademIndex/2026.other.121766

3. CRISPR activation and interference screens decode stimulation responses in primary human T cells

   Ralf Schmidt, Zachary Steinhart, Madeline Layeghi +6

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.475858